Skip to content
10-Q

Quarterly Report

RESPONSE BIOMEDICAL CORP

0001437749-15-020673

← back to feed
Filed
Nov 13, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 1, 2015 9.93M sh
Operating Cash Flow Q3 2015 · Sep 30, 2015 821K
Operating Cash Flow Q3 2015 · Sep 30, 2014 −2.28M
Long Term Debt Q3 2015 · Sep 30, 2015 555K
Long Term Debt Q3 2015 · Dec 31, 2014 1M
Short Term Debt Q3 2015 · Sep 30, 2015 840K
Short Term Debt Q3 2015 · Dec 31, 2014 546K
Stockholders Equity Q3 2015 · Sep 30, 2015 −992K
Stockholders Equity Q3 2015 · Dec 31, 2013 −1.48M
Current Liabilities Q3 2015 · Sep 30, 2015 7.19M
Current Liabilities Q3 2015 · Dec 31, 2014 7.11M
Total Liabilities Q3 2015 · Sep 30, 2015 13.64M
Total Liabilities Q3 2015 · Dec 31, 2014 14.52M
Current Assets Q3 2015 · Sep 30, 2015 5.74M
Current Assets Q3 2015 · Dec 31, 2014 6.34M
Total Assets Q3 2015 · Sep 30, 2015 12.65M
Total Assets Q3 2015 · Dec 31, 2014 13.63M
Net Income Q3 2015 · Dec 31, 2014 −2.09M
Net Income Q3 2015 · Sep 30, 2014 −1.12M
Net Income Q3 2015 · Sep 30, 2014 −2.35M
Shares Diluted Q3 2015 · Sep 30, 2014 7.95M sh
Shares Diluted Q3 2015 · Sep 30, 2014 7.92M sh
Capex Q3 2015 · Sep 30, 2014 179K
Cash And Equivalents Q3 2015 · Sep 30, 2014 1.71M
Cash And Equivalents Q3 2015 · Dec 31, 2013 2.96M
Eps Diluted Q3 2015 · Sep 30, 2014 −0.14
Eps Diluted Q3 2015 · Sep 30, 2014 −0.30
Eps Basic Q3 2015 · Sep 30, 2014 −0.14
Eps Basic Q3 2015 · Sep 30, 2014 −0.30
Sga Expense Q3 2015 · Sep 30, 2014 1.29M
Sga Expense Q3 2015 · Sep 30, 2014 2.69M
Rd Expense Q3 2015 · Sep 30, 2014 881K
Rd Expense Q3 2015 · Sep 30, 2014 2.51M
Gross Profit Q3 2015 · Sep 30, 2014 705K
Gross Profit Q3 2015 · Sep 30, 2014 3.2M
Cost Of Revenue Q3 2015 · Sep 30, 2014 1.49M
Cost Of Revenue Q3 2015 · Sep 30, 2014 4.64M
Revenue Q3 2015 · Sep 30, 2014 2.2M
Revenue Q3 2015 · Sep 30, 2014 7.84M